I'm LongbridgeAI, I can summarize articles.By Michael Kramer
A looming oversupply problem could weigh on the stock over the next year
Members of Anthropic's board of directors appear at the Nasdaq exchange before Wednesday's IPO. Company insiders have billions of shares still locked up.
The Anthropic IPO thus far hasn't been great for investors who bought at the opening price of $111.50 on its first day of trading. It hasn't really even been that great for those who got bought at the offering price of $83, either. As of the close of trading Friday, the shares are trading at just $88.30.
Most investors never read an IPO prospectus, but they really should at least glance at Anthropic's (ANT). Probably one of the most important sections to read closely is the one on shares eligible for future sale. A quick look suggested the IPO could have issues once it started trading.
'Shares eligible for future sale'
The prospectus shows that the deal size was 980 million shares, and it grew to 1.127 billion after the underwriters exercised their option to buy another 147 million. That sounds like a big number, but with the company's 13.4 billion shares outstanding (page 20), the deal was only about 8.4% of the total company.
More importantly, it also shows that on the first trading day after the prospectus, up to 315 million shares of Class A stock (page 317) held by its non-founder directors, officers, and current and former employees and consultants were eligible to be sold. That comes to about 28% of the offering size.
Of course, that doesn't mean that everyone who had the chance to sell on Wednesday sold. There is no way to know how many of those holders sold, at least not right away, but the stock did trade 857 million shares on its first day of trading, so the deal didn't even turn itself over. But that volume alone doesn't tell us how many shares those holders sold.
But the issues don't stop there. From a liquidity standpoint, not only did 315 million shares already become available to trade on top of the initial offering size, but the prospectus also reveals that up to 303 million Class A and N shares come off lock-up on Dec. 15, another 303 million shares of Class A and N come off lock-up on Jan. 5, another 353 million shares on Jan. 19 and 353 million shares on Feb. 2. So, over the first 76 calendar days, about 1.6 billion shares will be eligible to be sold, taking the initial float of 1.127 billion and more than doubling it to about 2.75 billion.
Supply will continue to grow
Worse, on the second full trading day after it releases its earnings results for the year ended Dec. 31, 2026, another 1.7 billion shares come off lock-up. This lock-up release schedule continues over the next year, with more shares released roughly every two weeks after each earnings report, until all the shares are eligible to be sold. The numbers become a bit eye-watering.
None of this even considers whether the stock's fundamentals make sense or answers questions investors have had about the company's potential profitability, future spending commitments or debt burden.
Generally, when supply increases, price declines. So as more stock comes up for sale, the stock price may continue to drift lower if these holders choose to sell their shares. It adds up to quite a lot over time.
A balancing act
The prospectus states that after the offering and a concurrent private placement, and with the underwriters' option exercised in full, the company had roughly 7.73 billion shares of Class A common stock and 5.64 billion shares of Class N common stock, or about 13.4 billion in total. It also says that lock-up and market standoff agreements cover about 15.5 billion shares (page 21), a figure that counts shares issuable from stock options, restricted stock units and convertible notes. That means that roughly 15.5 billion shares, in total, can come off lock-up over time. Again, that doesn't mean they all come up for sale. They may never come up for sale, but it is still a lot of lingering supply and a potential overhang.
Over time, as the lock-up period unwinds and the shares settle, the market will come into better balance, where sellers and buyers can meet. The only question is at what price. At least from the outside, that price doesn't seem to be where the shares opened on their first day of trading.
If Anthropic's stock fails to live up to the hype, it may only be because there was simply too much of it.
Michael Kramer is the founder of Mott Capital Management and a long-only investor focused on macroeconomic themes. He analyzes long-term macro trends and short-term market risk using technical analysis, fundamentals and options-market positioning. See here for further disclosures.
-Michael Kramer
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-20-26 1639ET
Login to unlock3,573characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.
